skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Simple Search

Results 1 - 20 of 741  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: Free E- Journals remove Database: PubMed Central (Open access) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis
Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis
Material Type:
Article 		Add to My Research

Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis

Oncotarget, 2016-09, Vol.7 (36), p.57671-57678

Copyright: © 2016 Yang et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.9808 ;PMID: 27275544

Full text available

Citations Cited by
2
Does access to credit services influence availability of essential child medicines and licensing status among private medicine retail outlets in Uganda?
Does access to credit services influence availability of essential child medicines and licensing status among private medicine retail outlets in Uganda?
Material Type:
Article 		Add to My Research

Does access to credit services influence availability of essential child medicines and licensing status among private medicine retail outlets in Uganda?

Journal of pharmaceutical policy and practice, 2017-09, Vol.10 (1), p.30-30, Article 30 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-017-0116-8 ;PMID: 28948025

Full text available

Citations Cited by
3
Reducing Sodium Intake in Children: A Public Health Investment
Reducing Sodium Intake in Children: A Public Health Investment
Material Type:
Article 		Add to My Research

Reducing Sodium Intake in Children: A Public Health Investment

The journal of clinical hypertension (Greenwich, Conn.), 2015-09, Vol.17 (9), p.657-662 [Peer Reviewed Journal]

2015 The Authors. Published by Wiley Periodicals, Inc. ;2015 The Authors. The Journal of Clinical Hypertension Published by Wiley Periodicals, Inc. ;ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/jch.12615 ;PMID: 26346989

Full text available

Citations Cited by
4
Making the investment case for national regulatory authorities
Making the investment case for national regulatory authorities
Material Type:
Article 		Add to My Research

Making the investment case for national regulatory authorities

Journal of pharmaceutical policy and practice, 2021-01, Vol.14 (1), p.16-16, Article 16 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-021-00299-7 ;PMID: 33478590

Full text available

Citations Cited by
5
Societal return on investment may greatly exceed financial return on investment in neurotechnology-based therapies: A case study in epilepsy therapy development
Societal return on investment may greatly exceed financial return on investment in neurotechnology-based therapies: A case study in epilepsy therapy development
Material Type:
Article 		Add to My Research

Societal return on investment may greatly exceed financial return on investment in neurotechnology-based therapies: A case study in epilepsy therapy development

Surgical neurology international, 2021-04, Vol.12, p.180, Article 180

Copyright: © 2021 Surgical Neurology International 2021 ;ISSN: 2152-7806 ;ISSN: 2229-5097 ;EISSN: 2152-7806 ;DOI: 10.25259/SNI_230_2020 ;PMID: 34084608

Full text available

Citations Cited by
6
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach
Material Type:
Article 		Add to My Research

Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach

Journal of pharmaceutical policy and practice, 2023-07, Vol.16 (1), p.84-84, Article 84 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-023-00590-9 ;PMID: 37408046

Full text available

Citations Cited by
7
Health supply chain system in Uganda: current issues, structure, performance, and implications for systems strengthening
Health supply chain system in Uganda: current issues, structure, performance, and implications for systems strengthening
Material Type:
Article 		Add to My Research

Health supply chain system in Uganda: current issues, structure, performance, and implications for systems strengthening

Journal of pharmaceutical policy and practice, 2022-03, Vol.15 (1), p.14-14, Article 14 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-022-00412-4 ;PMID: 35232485

Full text available

Citations Cited by
8
Are valve clinics a sound investment for the health service? A cost-effectiveness model and an automated tool for cost estimation
Are valve clinics a sound investment for the health service? A cost-effectiveness model and an automated tool for cost estimation
Material Type:
Article 		Add to My Research

Are valve clinics a sound investment for the health service? A cost-effectiveness model and an automated tool for cost estimation

Open heart, 2015-10, Vol.2 (1), p.e000275-e000275 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2015 ;ISSN: 2053-3624 ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2015-000275 ;PMID: 26568835

Full text available

Citations Cited by
9
Are Electrode Caps Worth the Investment? An Evaluation of EEG Methods in Undergraduate Neuroscience Laboratory Courses and Research
Are Electrode Caps Worth the Investment? An Evaluation of EEG Methods in Undergraduate Neuroscience Laboratory Courses and Research
Material Type:
Article 		Add to My Research

Are Electrode Caps Worth the Investment? An Evaluation of EEG Methods in Undergraduate Neuroscience Laboratory Courses and Research

Journal of undergraduate neuroscience education, 2016, Vol.15 (1), p.A29-A37 [Peer Reviewed Journal]

Copyright © 2016 Faculty for Undergraduate Neuroscience 2016 ;ISSN: 1544-2896 ;EISSN: 1544-2896 ;PMID: 27980468

Full text available

Citations Cited by
10
Counting the cost of public and philanthropic R D funding: the case of olaparib
Counting the cost of public and philanthropic R D funding: the case of olaparib
Material Type:
Article 		Add to My Research

Counting the cost of public and philanthropic R D funding: the case of olaparib

Journal of pharmaceutical policy and practice, 2022-12, Vol.15 (1) [Peer Reviewed Journal]

EISSN: 2052-3211 ;DOI: 10.1186/s40545-022-00445-9

Full text available

Citations Cited by
11
Financial Impact of Embedded Injury Prevention Experts in U.S. Army Initial Entry Training
Financial Impact of Embedded Injury Prevention Experts in U.S. Army Initial Entry Training
Material Type:
Article 		Add to My Research

Financial Impact of Embedded Injury Prevention Experts in U.S. Army Initial Entry Training

Journal of athletic training, 2023-06, Vol.58 (6), p.511-518 [Peer Reviewed Journal]

Copyright National Athletic Trainers Association Dec 2022 ;Copyright National Athletic Trainers Association Jun 2023 ;ISSN: 1062-6050 ;EISSN: 1938-162X ;DOI: 10.4085/1062-6050-0353.22 ;PMID: 36583956

Full text available

Citations Cited by
12
Evidence for Economic Evaluations of Athletic Trainer Services
Evidence for Economic Evaluations of Athletic Trainer Services
Material Type:
Article 		Add to My Research

Evidence for Economic Evaluations of Athletic Trainer Services

Journal of athletic training, 2022-07, Vol.57 (7), p.632-639 [Peer Reviewed Journal]

by the National Athletic Trainers' Association, Inc. ;Copyright National Athletic Trainers Association Feb 2022 ;by the National Athletic Trainers' Association, Inc 2022 ;ISSN: 1062-6050 ;EISSN: 1938-162X ;DOI: 10.4085/1062-6050-0666.21 ;PMID: 35142843

Full text available

Citations Cited by
13
Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups
Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups
Material Type:
Article 		Add to My Research

Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

Open heart, 2019-01, Vol.6 (1), p.e000939-e000939 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0 Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2018-000939 ;PMID: 30997129

Full text available

Citations Cited by
14
Variabilities in the mortality-related resource utilisation for congenital heart disease
Variabilities in the mortality-related resource utilisation for congenital heart disease
Material Type:
Article 		Add to My Research

Variabilities in the mortality-related resource utilisation for congenital heart disease

Open heart, 2016-05, Vol.3 (1), p.e000415-e000415 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2016-000415 ;PMID: 27175289

Full text available

Citations Cited by
15
Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades
Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades
Material Type:
Article 		Add to My Research

Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades

Journal of pharmaceutical policy and practice, 2023-09, Vol.16 (1), p.1-109, Article 109 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Dr. Zaheer-Ud-Din Babar and Auckland UniServices Ltd. 2023 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-023-00612-6 ;PMID: 37770995

Full text available

Citations Cited by
16
Counting the cost of public and philanthropic R&D funding: the case of olaparib
Counting the cost of public and philanthropic R&D funding: the case of olaparib
Material Type:
Article 		Add to My Research

Counting the cost of public and philanthropic R&D funding: the case of olaparib

Journal of pharmaceutical policy and practice, 2022-08, Vol.15 (1), p.1-47, Article 47 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-022-00445-9 ;PMID: 35974344

Full text available

Citations Cited by
17
State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines
State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines
Material Type:
Article 		Add to My Research

State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines

Journal of pharmaceutical policy and practice, 2022-08, Vol.15 (1), p.1-50, Article 50 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-022-00442-y ;PMID: 35986397

Full text available

Citations Cited by
18
Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
Material Type:
Article 		Add to My Research

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)

Disease models & mechanisms, 2020-02, Vol.13 (2) [Peer Reviewed Journal]

2020. Published by The Company of Biologists Ltd. ;2020. This work is licensed under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Published by The Company of Biologists Ltd 2020 ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.042903 ;PMID: 32066568

Full text available

Citations Cited by
19
EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
Material Type:
Article 		Add to My Research

EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?

Journal of pharmaceutical policy and practice, 2021-04, Vol.14 (1), p.37-37, Article 37 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/s40545-021-00317-8 ;PMID: 33910624

Full text available

Citations Cited by
20
Quality of Actions to Control Cervical Cancer in Bahia, Brazil
Quality of Actions to Control Cervical Cancer in Bahia, Brazil
Material Type:
Article 		Add to My Research

Quality of Actions to Control Cervical Cancer in Bahia, Brazil

Asian Pacific journal of cancer prevention : APJCP, 2021-08, Vol.22 (8), p.2343-2349 [Peer Reviewed Journal]

ISSN: 1513-7368 ;EISSN: 2476-762X ;DOI: 10.31557/APJCP.2021.22.8.2343 ;PMID: 34452544

Full text available

Citations Cited by

Results 1 - 20 of 741  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1976  (15)
  2. 1976 To 1992  (18)
  3. 1993 To 2002  (33)
  4. 2003 To 2013  (155)
  5. After 2013  (521)
  6. More options open sub menu

Resource Type 

  1. Articles  (737)
  2. Reports  (2)
  3. Conference Proceedings  (1)
  4. Reviews  (1)
  5. More options open sub menu

Language 

  1. English  (739)
  2. Japanese  (58)
  3. Korean  (2)
  4. French  (1)
  5. Norwegian  (1)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait